Preclinical Evaluation of Effects of KP-001, a Selective Phosphatidylinositol 3-Kinase Alpha (PI3Kα) Inhibitor, on Human Immune Cell Function in Comparison with Existing Drugs for Refractory Vascular Malformations
Biological and Pharmaceutical Bulletin · 12.11.2026 · 49 (11) · 1866-1872
DOI: 10.1248/bpb.b26-00312 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 12.11.2026. Verfasst von Daiki Kato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, Drug Research Center, Kaken Pharmaceutical Co., Ltd., 14, Shinomiya Minamigawara-cho, Yamashina-ku, Kyoto 607-8042, Japan. Hauptthemen laut MEDLINE: Phosphoinositide-3 Kinase Inhibitors, Class I Phosphatidylinositol 3-Kinases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Department, Drug Research Center, Kaken Pharmaceutical Co., Ltd., 14, Shinomiya Minamigawara-cho, Yamashina-ku, Kyoto 607-8042, Japan.
Zitieren
APA
Kato, D., & Koyama, E. (2026). Preclinical Evaluation of Effects of KP-001, a Selective Phosphatidylinositol 3-Kinase Alpha (PI3Kα) Inhibitor, on Human Immune Cell Function in Comparison with Existing Drugs for Refractory Vascular Malformations. Biological and Pharmaceutical Bulletin, 49(11), 1866-1872. https://doi.org/10.1248/bpb.b26-00312
Vancouver
Kato D, Koyama E. Preclinical Evaluation of Effects of KP-001, a Selective Phosphatidylinositol 3-Kinase Alpha (PI3Kα) Inhibitor, on Human Immune Cell Function in Comparison with Existing Drugs for Refractory Vascular Malformations. Biological and Pharmaceutical Bulletin. 2026;49(11):1866-1872. doi:10.1248/bpb.b26-00312
BibTeX
@article{Kato2026,
author = {Kato, Daiki and Koyama, Erika},
title = {Preclinical Evaluation of Effects of KP-001, a Selective Phosphatidylinositol 3-Kinase Alpha (PI3Kα) Inhibitor, on Human Immune Cell Function in Comparison with Existing Drugs for Refractory Vascular Malformations},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
volume = {49},
number = {11},
pages = {1866--1872},
doi = {10.1248/bpb.b26-00312}
}
EUVIMED